CASI Pharmaceuticals (CASIF) Cash & Equivalents (2021 - 2026)
CASI Pharmaceuticals' Cash & Equivalents came in at $3.77 million for Q2 2026, down 44.1% from $6.74 million a year earlier.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, CASI Pharmaceuticals' Cash & Equivalents was $5.63 million, down 58.2% from FY2024.
- Cash & Equivalents has declined in each of the last three years, with a four-year compound annual growth rate of -38.2% (FY2021 to FY2025).
- Going back by year, Cash & Equivalents was $13.47 million in FY2024 (-21.2%), $17.08 million in FY2023 (-63.7%), $47.11 million in FY2022 (+21.7%) and $38.7 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents in data going back to Q4 2021.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2022 (growth of 21.7%), and the weakest in Q3 2025 (a decline of 71.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | 3.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.77 Mn |
| Dec 31, 2025 | 5.63 Mn |
| Sep 30, 2025 | 4.69 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Dec 31, 2024 | 13.47 Mn |
| Sep 30, 2024 | 16.54 Mn |
| Jun 30, 2024 | 9.53 Mn |
| Mar 31, 2024 | 12.20 Mn |
| Dec 31, 2023 | 17.08 Mn |
| Sep 30, 2023 | 19.98 Mn |
| Jun 30, 2023 | 16.92 Mn |
| Mar 31, 2023 | 16.59 Mn |
| Dec 31, 2022 | 47.11 Mn |
| Dec 31, 2021 | 38.70 Mn |
API Access
CASI Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();